| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |